Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment

IMPORTANCE: Age-related macular degeneration (AMD) remains the leading cause of blindness in developed countries, and affects more than 150 million worldwide. Despite effective anti-angiogenic therapies for the less prevalent neovascular form of AMD, treatments are lacking for the more prevalent dry...

Descripción completa

Detalles Bibliográficos
Autores principales: Vavvas, Demetrios G., Daniels, Anthony B., Kapsala, Zoi G., Goldfarb, Jeremy W., Ganotakis, Emmanuel, Loewenstein, John I., Young, Lucy H., Gragoudas, Evangelos S., Eliott, Dean, Kim, Ivana K., Tsilimbaris, Miltiadis K., Miller, Joan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816836/
https://www.ncbi.nlm.nih.gov/pubmed/27077128
http://dx.doi.org/10.1016/j.ebiom.2016.01.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816836/
https://www.ncbi.nlm.nih.gov/pubmed/27077128
http://dx.doi.org/10.1016/j.ebiom.2016.01.033

Ejemplares similares